Second Sight reports gross loss, higher net loss for third quarter
Second Sight Medical Products reported a gross loss of $1.4 million in the third quarter compared with a gross profit of $1.5 million in the third quarter of 2015.
A company press release attributed the loss to lower revenues, production costs and excess inventory reserve adjustments.
Quarterly net loss was $8.5 million, or $0.20 per share, compared with a net loss of $4.7 million, or $0.13 per share, a year ago.
Net sales totaled $1.2 million compared with $2.2 million in the third quarter 2015.
Total operating expenses rose by $1 million to $7.1 million in the third quarter due to higher research and development costs and higher stock-based compensation and salaries, the release said.